secwatch / observer
8-K filed February 6, 2024, 6:59 PM ET ticker CRBP CIK 0001595097
leadership confidence high sentiment negative materiality 0.40

Corbus Pharmaceuticals CSO Rachael Brake resigns effective Feb 19, 2024

Corbus Pharmaceuticals Holdings, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Rachael Brake

Chief Scientific Officer
CRBP · Corbus Pharmaceuticals Holdings, Inc.
Effective
2024-02-19
Filed
February 6, 2024, 6:59 PM ET
On February 2, 2024, Rachael Brake, Ph.D., Chief Scientific Officer of Corbus Pharmaceuticals Holdings, Inc. (the “Company”), submitted a notice of resignation to the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Rachael Brake resigned as Chief Scientific Officer at Corbus Pharmaceuticals Holdings, Inc..

Action
resigned
Role
Chief Scientific Officer
Exact text from the filing
On February 2, 2024, Rachael Brake, Ph.D., Chief Scientific Officer of Corbus Pharmaceuticals Holdings, Inc. (the “Company”), submitted a notice of resignation to the Company.
View on SEC.gov

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-24-011733
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.